On May 9, 2023 BostonGene reported that as part of its ongoing commitment to improving the diagnosis and personalized treatment recommendations for cancer patients, it will participate in and present at PEGS Boston Summit on May 15 – 19, 2023, at the Hynes Convention Center (Press release, BostonGene, MAY 9, 2023, View Source [SID1234631313]). The event is the leading biologics event covering all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity, and more. BostonGene will also exhibit at booth #228.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
BostonGene session details can be found below:
Comprehensive genomic and immune profiling of tumor tissue and peripheral blood to predict immunotherapy response and identify mechanisms of immune escape
Monday, May 15 | 2:50 PM ET
Speaker: Michael Goldberg, PhD, Director of Immunology, BostonGene
The session will address how BostonGene’s innovative AI and ML-based solutions can precisely predict immunotherapy responses, resistance, and immune-related adverse events. The presentation will underscore how our comprehensive genomic and immune profiling platform will assist in providing patients with the most effective treatments and mechanistic stratification that will propel bringing novel agents and combinations into the clinic and ultimately accelerate the next phase of drug discovery.
To learn more, or to schedule a meeting with BostonGene during PEGS Boston 2023, please contact Maria Proia at [email protected].